Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Accelerating patient recruitment post-COVID-19

July 12, 2022 | Pharma, clinical trials, innovative trials, patient recruitment, pharmaceutical 

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

In a recent webinar Kate Shaw,Innovative Trials’ Founder & CEO,  Whitney Taynton, Unit Head at Innovative Trials, and Jane Thurston, Senior Patient Recruitment Lead for Parexel, discussed strategies for accelerating patient recruitment in clinical trials post-COVID-19 that will satisfy both sites and sponsors.

Read more here

This content was provided by Innovative Trials

Company Details

- PMLiVE

Innovative Trials

Email
Website

 Latest Content from  Innovative Trials 

Lupus Awareness Month

In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.

Black community representation in clinical trials

This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

Innovative Trials named Best global Patient Recruitment Company of 2021

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

Queen’s Award Highlights Video

Innovative Trials was awarded the Queen’s Award for Enterprise, and this video includes highlights of the ceremony days at the HQ in Letchworth.

Innovative Trials wins the Queen’s Award

Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment